Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Existe información en español para pacientes y cuidadores, para acceder, haga clic sobre “Select” al lado de “I am a U.S. Patient / Caregiver”.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Bumetanide Injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

4 mL
Single-dose Vial

NDC 0409-1412-34
Rx only

Bumetanide
Injection, USP

1 mg/4 mL (0.25 mg/mL)

INTRAVENOUS or
INTRAMUSCULAR USE

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

PRINCIPAL DISPLAY PANEL - 4 mL Vial Box

4 mL 10 Single-dose Vials
Sterile Injection

NDC 0409-1412-04
Contains 10 of NDC 0409-1412-34
Rx only

Bumetanide Injection, USP

1 mg/4 mL (0.25 mg/mL)

INTRAVENOUS or INTRAMUSCULAR USE

Hospira

PRINCIPAL DISPLAY PANEL - 4 mL Vial Box

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

10 mL
Multi-dose Vial

NDC 0409-1412-40
Rx only

Bumetanide
Injection, USP

2.5 mg/10 mL
(0.25 mg/mL)

INTRAVENOUS or INTRAMUSCULAR USE
Protect from light.

Distributed by Hospira, Inc.
Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box

10 mL 10 Multi-dose Vials
Sterile Injection

NDC 0409-1412-10
Contains 10 of NDC 0409-1412-40
Rx only

Bumetanide Injection, USP

2.5 mg/10 mL (0.25 mg/mL)

INTRAVENOUS or INTRAMUSCULAR USE

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event